As global markets experience a rally, with small-cap stocks leading the charge, Asian tech companies are capturing investor interest amid optimism in the domestic tech sector and strong market turnover. In this environment, identifying high-growth tech stocks involves looking for companies that demonstrate resilience and adaptability in response to evolving economic conditions and policy changes.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medy-Tox Inc. is a biopharmaceutical company based in South Korea with a market capitalization of ₩832.54 billion.
Operations: Medy-Tox Inc. generates revenue primarily from its biotechnology segment, amounting to approximately ₩241.80 billion. The company’s operations focus on the development and commercialization of biopharmaceutical products in South Korea.
Medy-Tox has demonstrated remarkable financial agility, with earnings surging by 103.6% over the past year, significantly outpacing the Biotech industry’s growth of 44.3%. This performance is underpinned by a robust annual earnings forecast of 49.9%, eclipsing the broader Korean market’s expectation of 33.5%. Additionally, recent strategic moves to stabilize its stock price through a share repurchase program reflect a proactive approach to enhancing shareholder value; from late November to early December 2025 alone, Medy-Tox repurchased nearly 24,000 shares for KRW 2.999 billion. This blend of aggressive financial growth and strategic market maneuvers positions Medy-Tox as a dynamic player in Asia’s high-growth tech landscape.
KOSDAQ:A086900 Earnings and Revenue Growth as at Jan 2026
Simply Wall St Growth Rating: ★★★★★★
Overview: Asia Vital Components Co., Ltd., along with its subsidiaries, specializes in providing thermal solutions globally and has a market capitalization of NT$522.10 billion.
Operations: The company generates revenue primarily from its Overseas Operating Department, contributing NT$129.35 billion, and the Integrated Management Division, contributing NT$93.88 billion.
Asia Vital Components has demonstrated a robust performance with its recent earnings report showing a doubling of sales to TWD 38.9 billion in Q3 2025 from TWD 19.1 billion the previous year, and net income soaring to TWD 5.3 billion from TWD 2.3 billion. This growth trajectory is supported by an annual revenue increase forecasted at 31.5% and earnings expected to rise by 33.1% per year, outpacing the broader Taiwanese market’s projections significantly. The company’s aggressive expansion in tech sectors is further evidenced by its substantial investment in R&D, aligning with industry demands for continuous innovation and advancement in high-tech components.
TWSE:3017 Revenue and Expenses Breakdown as at Jan 2026
Simply Wall St Growth Rating: ★★★★★★
Overview: Fositek Corp. specializes in the design and manufacturing of metal stamping products across Asia, the United States, and Europe, with a market capitalization of NT$88.78 billion.
Operations: Fositek Corp. generates revenue primarily from its Electronic Components & Parts segment, amounting to NT$11.21 billion. The company operates in key markets including Asia, the United States, and Europe.
Fositek’s recent financial performance underscores its burgeoning presence in the high-tech sector in Asia, with Q3 sales surging to TWD 3.57 billion from TWD 1.99 billion year-over-year and net income more than doubling to TWD 687 million. This growth is propelled by a robust increase in earnings, forecasted at an annual rate of 52.1%, significantly outpacing the broader Taiwanese market’s average of 21.3%. The company’s commitment to innovation is evident from its substantial R&D investments, aligning with industry trends towards enhanced technological capabilities and efficiency improvements in electronic segments.
TWSE:6805 Earnings and Revenue Growth as at Jan 2026
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include KOSDAQ:A086900 TWSE:3017 and TWSE:6805.
